Skip to main content

Table 8 Factors associated with EFS rate

From: The effect of ERCC1 and ERCC2 gene polymorphysims on response to cisplatin based therapy in osteosarcoma patients

Variables

P value

Hazard ratio

95.0% CI

ERCC1 8092 C allele

0.044

59.008 (Reference =1)

1.122–3102.7

ERCC2 312 G allele

0.562

2.085 (Reference = 1)

0.174–24.955

Histology

0.026

0.149 (Reference = 1)

0.028–0.792

Presence of metastasis

0.078

0.406 (Reference = 1)

0.149–1.106

Back to article page

BMC Medical Genetics

ISSN: 1471-2350

Contact us